New Clinical Evidence Shows GyroStim Accelerates Clinical Improvement Up to 5.7x Faster
This scientific brief explores the established neuroscience, breakthrough technology, and promising clinical findings behind FDA-cleared, FDA Breakthrough Device-designated GyroStim neurotechnology.COLORADO SPRINGS, Colo., Nov. 18, 2026 /PRNewswire/ -- UltraThera Technologies, Inc., developer of GyroStim®, today announced the release of GyroStim:…

















